NCCN Guidelines Insights: Breast Cancer, Version 1.2017

Restricted access

These NCCN Guidelines Insights highlight the important updates/changes to the surgical axillary staging, radiation therapy, and systemic therapy recommendations for hormone receptor–positive disease in the 1.2017 version of the NCCN Guidelines for Breast Cancer. This report summarizes these updates and discusses the rationale behind them. Updates on new drug approvals, not available at press time, can be found in the most recent version of these guidelines at NCCN.org.

Provided content development and/or authorship assistance.

Supplementary Materials

    • Supplemental Material (PDF 299 KB)
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 3077 3077 245
PDF Downloads 770 770 61
EPUB Downloads 0 0 0